Epicatechin is a promising novel inhibitor of SARS-CoV-2 entry by disrupting interactions between angiotensin-converting enzyme type 2 and the viral receptor binding domain: A computational/simulation study. - Mohammed Baqur S. Al-Shuhaib; Hayder O. Hashim; Jafar M. B. Al-Shuhaib (Comput. Biol. Medicine, 2022)